What laboratory tests are used to assess male fertility?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Tests for Male Fertility Assessment

The initial screening for male fertility should include a reproductive history and two semen analyses performed at least one month apart. 1

Initial Laboratory Evaluation

Semen Analysis

Semen analysis is the cornerstone of male fertility assessment and should include:

  • Volume: 1.4-5.0 mL (lower reference limit: 1.4 mL)
  • pH: >7.2
  • Sperm concentration: >16 million/mL (lower reference limit)
  • Total sperm number: >39 million per ejaculate
  • Motility:
    • Progressive motility: >30%
    • Total motility: >42%
  • Morphology: >4% normal forms
  • Vitality: >54% live sperm

1, 2

Collection Instructions

  • Abstain from sexual activity for 2-3 days before collection
  • Collect by masturbation or intercourse using specialized collection condoms
  • Keep specimen at room or body temperature during transport
  • Examine within one hour of collection 1

Important Considerations

  • Semen parameters are highly variable biological measures
  • At least two analyses should be performed, especially if the first shows abnormal parameters
  • Point-of-care and mail-in tests may provide some information but are not substitutes for laboratory analysis 1

Additional Laboratory Testing

Endocrine Evaluation

Perform endocrine evaluation if:

  • Sperm concentration <10 million/mL
  • Sexual function is impaired
  • Clinical findings suggest endocrinopathy

Minimum initial endocrine evaluation:

  • Serum testosterone
  • Serum follicle-stimulating hormone (FSH) 1, 2

Post-Ejaculatory Urinalysis

Indicated when:

  • Ejaculate volume <1 mL (except in bilateral vasal agenesis or hypogonadism)
  • Suspicion of retrograde ejaculation 1

Specialized Testing

Genetic Testing

Indicated for:

  • Men with nonobstructive azoospermia
  • Men with severe oligospermia (<5-10 million sperm/mL)
  • Men with congenital bilateral absence of vas deferens

Types of genetic tests:

  • Karyotyping
  • Y-chromosome microdeletion analysis
  • Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation testing (for female partners of men with congenital bilateral absence of vas deferens) 1

Sperm DNA Fragmentation Testing

Consider in cases of:

  • Failed assisted reproductive technology cycles
  • Recurrent pregnancy losses (two or more) 1

Imaging Studies

Scrotal Ultrasonography

Indicated when:

  • Physical examination of scrotum is difficult or inadequate
  • Testicular mass is suspected 1

Transrectal Ultrasonography (TRUS) or Pelvic MRI

May be recommended for:

  • Men with suspected ejaculatory duct obstruction
    • Acidic, azoospermic semen with volume <1.4 mL
    • Normal serum testosterone
    • Palpable vas deferens 1

Common Pitfalls and Caveats

  1. Single semen analysis can be misleading: Parameters fluctuate substantially; at least two analyses are recommended 1

  2. WHO reference limits are based on the lowest 5th percentile of values from fertile males whose partners became pregnant within 12 months 1

  3. Routine use of ultrasonography for non-palpable varicoceles should be discouraged as treatment of non-palpable varicoceles does not improve fertility rates 1

  4. Specialized testing of semen (beyond basic analysis) is not required for diagnosis of male infertility but may be useful in select cases 1

  5. Interpreting FSH levels: Men with FSH >7.6 IU/L are more likely to have spermatogenic failure (non-obstructive azoospermia) 1, 2

By following this systematic approach to laboratory testing for male fertility, clinicians can effectively identify potential causes of infertility and guide appropriate treatment decisions.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Male Infertility Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.